Filer Snapshot

Eric Ostertag

CIK 0001765987. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

27

Latest filing

03 Feb 2023

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for PSTX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open owner activity Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Forms 3/4/5

4 filed on 03 Feb 2023 for CIK 0001765987.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$9.57M

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$9.57M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

PSTX
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego, CA, 92121

Filer intelligence

What SEC filings say about Eric Ostertag

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • Forms 3/4/5 show insider context for PSTX worth $9.57M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

PSTX

01 Feb 2023

$9.57M
Issuer page Owner page

Latest update

What changed recently for Eric Ostertag

Ownership report updated

Latest ownership report period: 01 Feb 2023. Open the source-backed page to inspect the fresh filing or facts context.

Update date

03 Feb 2023

Page type

Ownership filings

Latest period

01 Feb 2023

Ownership context was refreshed from SEC Forms 3/4/5 filed on 03 Feb 2023.

Open ownership filings Browse recent public updates

SEC filing record

CIK 0001765987 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
27
First seen
09 Jul 2020
Latest filing
03 Feb 2023
Entity
Individual

Observed form types

4 5 3/A 3

CIK-linked evidence first

Eric Ostertag SEC filings Eric Ostertag owner filings Open SEC filing index

Latest Filings

Showing the latest 12 of 27 SEC filings for Eric Ostertag.

Open full filing history
4 File 001-39376

FORM 4 SUBMISSION

Filing date
03 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
5 File 001-39376

FORM 5 SUBMISSION

Filing date
17 Jan 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
10 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
05 Aug 2022
Reporting date
03 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
22 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
10 Nov 2021
Reporting date
08 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
13 Oct 2021
Reporting date
11 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
05 Oct 2021
Reporting date
01 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
22 Sep 2021
Reporting date
20 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
15 Sep 2021
Reporting date
13 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

FORM 4 SUBMISSION

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .